Merck Sharp and Dohme (MSD) has announced that Mike Nally is to take on the role of managing director of the company’s operations in the UK and Ireland.
Nally will take over the role on January 1, 2014, moving from his current position as managing director of MSD in Sweden.
He replaces Deepak Khanna who has been appointed to a new senior VP role at MSD where he will lead the company’s oncology efforts across Europe.
As previously announced, Khanna will also step down from his role as president of the Association of the British Pharmaceutical Industry (ABPI) to be replaced by Pfizer’s Jonathan Emms.
Commenting on Nally’s work in Sweden, MSD said that “he has led the company to become a more customer centric organisation in a dynamic, payer-based environment”.